Eltrombopag tablet - Revolade | Apple pharmaceuticals

Eltrombopag 

DESCRIPTION

Eltrombopag is a prescription drug which is used under the guidance of the doctor.
Eltrombopag drug may be used as part of combination therapy. Thereby drug may need to take it with other medications.

INDICATION

Eltrombopag is mainly indicated for the treatment of patients having :

• Reduced platelet levels due to chronic immune thrombocytopenia
• Reduced platelet counts due to chronic hepatitis C virus infection

Severe Aplastic Anemia :

• First line treatment of severe Aplastic Anemia
• Treatment of refractory severe Aplastic Anemia

MECHANISM OF ACTION

Eltrombopag be part of the class of drugs called thrombopoietin (TPO) receptor agonists. Classification of drugs is an association of medications which work in a similar way. These drugs are often used to treat similar conditions. Eltrombopag works by raise cells in bone marrow and leads these cells to make various platelets. This effect reduces the risk of bleeding.

SIDE EFFECTS  

Common side effects:

• low red blood cells
• nausea
• fever
• weakness
• pain in head
• cough
• decreased appetite
• flu
• diarrhoea.

Serious side effects:

• Urine in dark color
• Yellowing of your skin
• Abdomen swelling
• Confusion
• Chest pain
• Dyspnea
• Cloudy vision
• Sensitivity to light
• Seeing circles around lights
• Swelling of legs.

PRECAUTION

The drug causes warning condition, call the doctor while new medication interaction Disease progression warning: Avoid using the drug while the patients have myelodysplastic syndrome (MDS), will increase the risk of death.

DRUG INTERACTION

Eltrombopag interaction with these drugs ezetimibe, glyburide, Olmesartan, repaglinide, valsartan, imatinib, irinotecan, lapatinib, methotrexate, mitoxantrone, Bosentan, sulfasalazine, and topotecan irinotecan leads an increase of side effects. hence the doctor may reduce your dosage of these drugs if required.

PREGNANCY 

Pregnancy category is C
Use the Eltrombopag with caution if asset outweighs risks. Animal studies reveal risk and human studies not available or neither animal nor human studies done.

LACTATION

The presence of Eltrombopag or metabolites in human milk, the drug has possible serious side effects for the breastfed child. The drug is not recommended during breastfeeding

STORAGE CONDITION

Store at room temperature 20° and 25°.
Discard the left-out medicine if not used within 30 minutes.

FOR MORE INFORMATION:

EMAIL:

applepharmaceutical@gmail.com

PHONE:

91- 9987711567

VISIT US:

Eltrombopag